請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35748
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 柯承恩 | |
dc.contributor.author | Su-Ling Tsai | en |
dc.contributor.author | 蔡素玲 | zh_TW |
dc.date.accessioned | 2021-06-13T07:08:05Z | - |
dc.date.available | 2005-08-01 | |
dc.date.copyright | 2005-08-01 | |
dc.date.issued | 2005 | |
dc.date.submitted | 2005-07-27 | |
dc.identifier.citation | 中文部份:
1.王詩鳳著,醫療品質與生產力變動之評估-以台灣醫療品質指標計畫(TQIP)為例,國防管理學院資源管理研究所碩士論文,民國93年。 2.石曜堂著,醫療品質評估,醫院11(2),民國67年,106-109。 3.行政院衛生署台南醫院感染管制委員會著,品質指標運用於婦科手術預防性抗生素使用模式之成效探討,第三屆台灣醫療品質促進年會,民國94年,94頁。 4.杜異珍著,醫院醫療品質保證計畫。醫院14(1),民國70年,5-10。 5.吳肖琪著,評估醫院醫療品質指標,行政院研究發展考核委員會,民國88年。 6.邱文達,林曉蕾著,醫療品質的新發展,新台北護理期刊3(2),民國90年,1-6。 7.李茂興譯,組織管理學,揚智文化事業股份有限公司,初版,民國90年,41-44。 8.周照芳等著,台灣醫療品質指標計畫資料分析及研究計劃,行政院衛生署醫政業務補助計畫,民國90年。 9.倪嘉慧著,台北醫療區域各級醫院醫療品質現況調查與分析,國立台灣大學公共衛生研究所碩士論文,民國83年。 10.胡煒明著,醫院參加「台灣醫療品質指標計畫」對醫療品質之影響-以五家台北市立綜合醫院為例,民國90年。 11.莊逸洲,黃崇哲著,醫務管理學系列財務、研究、品質暨設施管理,華杏出版社,初版,民國90年。 12.許國鋒,鄭育宛著,開腹式全子宮切除術之預防性抗生術使用評估,藥學雜誌(75),民國86年,111-118。 13.郭乃文著,何謂品質指標? 醫療品質指標理論與應用,合計圖書出版社,初版,民國93年,1-4。 14.陳佩妮著,醫療品質與經營績效關係之研究-以台北醫療區域各級醫院為例,國立台灣大學公共衛生研究所碩士論文,民國85年。 15.陳芳婷著,預防手術後感染之用藥,藥學雜誌(64),民國79年, 61-15。 16.張進祿著,外科手術前的預防性抗生素,臨床使用抗生素手冊,合記圖書出版社,民國80年,15-20。 17.張上淳等,醫學中心及區域醫院清淨手術預防性抗生素使用之分析,感控雜誌(11),341-354。 18.董玉麟著,國內五百大製造業品質成本實施現況與運作效益之探討,台灣大學工業工程研究所,民國88年。 19.董鈺琪著,地區教學以上醫院推行品質管理與技術教學關係之研究,台灣大學公共衛生學院醫療機構管理研究所碩士論文,民國86年。 20.廖薰香著,台灣醫療品質指標計畫介紹,醫療品質指標理論與應用,合計圖書出版社,初版,民國93年,31-48。 21.鄭伯壎譯,管理學,桂冠圖書公司,初版四刷,民國87年。 22.鍾敏英,劉文俊著,預防性抗生素使用之準則,基層醫學11(10),民國85年,193-198。 英文部分: 1.ACHS CEP., 1999, “Clinical Indicaror on Disk.”, NZ: ACHS Zetland. 2.Alicia J. et al., 1999, “Guideline for Prevention of Surgical Site Infection”, Infection Control and Hospital Epidemiology, Vol.20, NO.4, pp247-278. 3.Anonymous., 1999, “Antimicrobial prophylaxis in surgery”, Med Lett Drugs Ther, Vol.41, NO.1060, pp75-80. 4.Anonymous., 1998, “Antibiotic prophylaxis in surgery: summary of a Swedish-Norweugan Consensus Conference”, Scandinavian Journal of Infections Diseases, Vol.30, NO.6, pp547-557. 5.Anonymous, 2000, “Current trends in antibiotic prophylaxis in surgery”, Surgery, Vol.128, ppS14-S18. 6.Anonymous, 2001, “Antimicrobial prophylaxis in surgery”, Med Lett Drugs Ther, Vol.43, NO.1116-1117, pp92-97. 7.Briceland L.L. and Gugliemo B.J., 1997, “Antimicrobial prophylaxis for surgicall procedures”, Applied Therapeutics, Vol.55, pp1-6. 8.Burke J.F., 1961, “The effective period of preventive antibiotic action in experimental incisions and dermal lesions”, Surgery, Vol.50, pp161-168. 9.Burke J.F., 1977, “Preventing bacterial infection by coordinateing antibiotic and host activity: A time-dependent relationship”, South Med J, Vol.70(suppl.1), pp24. 10.Canadian Council on Health Services Accreditation, 2003, “A guide to the development and use of performance indicators. Ottawa: Canadian Council on Health Services Accreditation:1996”, Available at http://www.cchsa.ca. 11.Classen D.C., Evans R.S., Pestotnik S.L., Horn S.D., Menlove R.L., and Burke J.P., 1992, “The timing of prophylactic administration of antibiotics and the risk of surgical wound infection”, N Engl J Med, Vol.326, pp281-286. 12.Crosby P.B., 1979, “Quality may not be what you think it is. In The Art of Making Quality Certain”, New York: McGrew-Hill, Part 1, Chapter2. 13.Crotty G., Dale W., 2005, “Implementation of CMS-SIPP Measures in Surgery: Strategies to Achieve Succees”, 7th Annual NPSF Patient Safety Congress. 14.Dale W., Bratzler D.O., 2005, “Use of Antimicrobial Prophylaxis for Major Surgery-Baseline Results From the National Surgical Infection Prevention Project”, ARCH SURG, Vol.140, pp174-182. 15.Dellinger E.P., Gross P.A., Barrett T.L., et al., 1994, “Quality standard for antimicrobial prophylaxis in surgical procedures”, Cli Infect Dis, Vol.18, pp422-427. 16.Deming W.E., 1982, “Quality, Productivity and Competitive Position, MIT”, Center for Advanced Engineering, Cambridge, MA. 17.Donabedian A., 1987, “The quality in medical care”, Science, Vol.200, pp856-864. 18.Donabedian A., 1988, “The Quality of Care: How Can It Be Assessed?”, JAMA, Vol.260, pp1743-1748. 19.Donabedian A., 1995, “The Quality of Care: How Can It Be Assessed?. Quality in Health Care, Theory, Application and Evaluation”, In Graham No. eds, Maryland, An aspen Publication, pp1743-1748. 20.Epstein A.M., 1995, “Chapter 11: The Outcomes Movements: Will It Get Us Where We Want To Go?”, Quality in Health Care, Theory, Application and Evaluation, pp188-197. 21.Erbault M. et al., 2003, “Promoting quality improvement in French healthcare organizations: design and impact of a compendium of models and tools”, Qual Safe Health Care, Vol.12, pp372-376. 22.Fargher N., Morse and Dale, 1998, “Quality Cost: Planning the Trade-off between prevention and appraisal activities”, Journal of Cost Management, Vol.12, NO.1, pp14-21. 23.Feigenbaum A.V., 1961, Total Quality Control: Engineering and Management, 2nd. New York, McGraw-Hill. 24.Feigenbaum A.V., 1997, “No pain, no gain. ”, Chief Executive, Vol.121, pp36-40. 25.Fernandez A.H., et al, 2001, “Surgical antibiotic prophylaxis: effects in postoperative infections”, Eur J of Epidemiol, Vol.17, pp369-377. 26.Finkler S.A., 1993, “The quality management. Measuring costs of quality”, Hosp Cost Manag Account, Vol.5, pp1-6. 27.Finkler S.A., 1996, “Measuring costs of quality”, Hosp Cost Manag Account, Vol.7, pp1-6. 28.Fine C., 1986, “Quality Improvement and Learning in Project Systems”, Management Science, [Oct], pp1301-1315. 29.Francois P. et al., 2003 “Evaluating implementation of quality management systems in a teaching hospital’s clinical department’, International Journal for Quality in Health Care, Vol.15, NO.1, pp47-55. 30.Glezerman M. et al., 1999, “A model of efficient and continuous quality improvement in a clinical setting”, International Journal for Quality in Health Care, Vol.11, NO.3, pp227-232. 31.Greenberg K.D., Ramicone E., Chan L., Kahn K.L., 1990, “Cesarean deliveries for Medicaid patients: a compareson in public and private hospitals in Los Angeles county”, Am J. Obs&Gyn, Vol.180, NO.5, pp1177-1184. 32.Grimshaw J. et al., 2003, “Systematic reviews of the effectiveness of quality improvement strategies and programes”, Qual safe health care, Vol.12, pp298-293. 33.Gorecki P., et al, 1999, “Antibiotic Administration in Patients Undergoing Commen Surgical Procedures in a Community Teaching Hospital: The Chaos Continues”, World J. Surg., Vol.23, pp429-433. 34.Harvey G., Wensing M., 2003, “Methods for evaluation of small scale quality improvement projects”, Qual safe health care, Vol.12, pp210-214. 35.Haley R.W., Culver D.H., Morgan W.M., et al., 1985, “Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination”, Am J Epidemiol, Vol.121, pp206-215. 36.Hodgson J.E., Major B., Portmann K., 1957, “Prophylactic use tetracycline for first-trimester abortions: a clinic controlled trial”, Obstet Gynecol, Vol.45, pp574-578. 37.Hofer T.P., Bernstein S.J., Hayward R.A., DeMonner S., 1997, “Validating quality indicators for hospital care”, Jt Comm J Qual Improv, Vol.23, NO.9, pp455-467. 38.In Hell K., Hobsley M., (eds)., 1988, Antibiotic prophylaxis in surgery, 32nd world congress of surgery, Basle. Kreis & Co.Ltd. 39.Jarlier A. and Charvet-protat S., 2000, “Can improving quality decrease hospital costs?”, International Journal for Quality in Health Care, Vol.12, NO.2, pp125-131. 40.JCAHO, 1989, “Charecteristics of clinical indicators”, Qual Rev Bull, Vol.11, pp330-339. 41.John H.E., et al., 2001, “Management control and hospital cost reduction: additional evidence”, Journal of Accounting and Public Policy, Vol.20, pp73-88. 42.Juran J.M., 1951, Quality Control Handbook, New York: Mcgraw Hill. 43.Kaiser A.B.,1986, “Antimicrobial prophylaxis in surgery”, N Engl J Med, Vol.315, pp1129-1138. 44.Kazandjian V.A. et al, 2005, “Understanding safer practices in health care: a prologue for the role of indicators”, Journal of Evaluation in Clinical Practice, Vol.11, NO.2, pp161-170. 45.Kazandjian V.A. et al, 2003, “Are performance indicators generic? The international experience of the Quality Indicator Project”, Journal of Evaluation in Clinical Practice, Vol.9, NO.2, pp265-276. 46.Landro Laura., 2003, “How to Keep the Hospital From Making You Sicker”, The Wall Street Journal, Availability from: http://online.wsj.com/article_print/0,,SB106323038897073700,00.html. 47.Lohr K.N., Schroeder S.A., 1990, “A strategy fro quality assurance in medicare”, N Engl J Med, Vol.332, pp707-712. 48.Mainz J., 2003, “Defining and classifying clinical indicators for quality improvement”, International Journal for Quality in Health Care, Vol.15, NO.6, pp523-530. 49.Mats L., et al., 2004, “Postoperative infections and antibiotic prophylaxis for hysterectomy in Sweden: a study by the Swedish National Register for Gynecologic Surgery”, Acta Obstet Gynecol Scand, Vol.83, pp1202-1207. 50.Mefford R., 1989, “The Productivity Nexus of New Inventory and Quality Control Techniques”, Engineering Costs and Production Economics, pp21-28. 51.Mittendorf R., et al., 1993, “Avoiding serious infections associated with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis”, Am J Obstet Gynecol, Vol.169, pp1119-1124. 52.Ostrenga, M.R., 1991, “Return on Investment Through the Cost of Quality”, Cost Management, pp37-44. 53.Palmer R.H. and Reilly M.C., 1979, “Individual and Institutional Variables Which May Serve As Indicators of Quality of Medical Care”, Medical Care, Vol.7, NO.7, pp693-717. 54.Page C.P., Bohnen J.M., Fletcher J.R., et al., 1993 “Antimicrobial prophylaxis for surgical wounds guideline for clinical care”, Arch Surg, Vol.128, pp79-88. 55.Poli B.F, et al., 1980, “Randomized clinical trial of perioperative cefazolin in preventing infection after hysterectomy”, Lancet, Vol.1, pp437. 56.Polk HC Jr., Simpson C., Simmons B., et al., 1983 “Guidelines for prevention of surgical wound infection”, Arch Surg, Vol.118, pp1213-1217. 57.Silver A., et al., 1996, “Timeliness and Use of Antibiotic Prophylaxis in Selected Inpatient Surgical Procedures”, The American Journal of Surgery, Vol.171, pp548-552. 58.Stone H.H., Haney B.P., Kolb L.D., et al., 1979, “Prophylactic and preventive antibiotic therapy: timing, duration and economics”, Ann Surg, Vol.189, pp691-699. 59.Sweet R., Gibbs R., eds., 1995, Antibiotic Prophylaxis in Obstetrics and Gynecology, 3rd edn. Baltimore: Williams & Wilkins. 60.Talon D., et al., 2001 “Evaluation of Current pratices in surgical antimicrobial prophylaxis before and after implementation of local guidelines”, J Hosp Infect, Vol. 49, pp193-198. 61.Tanos V., Rojansky N., 1994, “Prophylactic antibiotics in abdominal hysterectomy”, J Am Coll Surg, Vol.179, pp593-600. 62.Terry R. Kazandjian V.A.,1996 “A hawthorne strategy:implications for performance measurement and improvement” Clinical Performance and and Quality Health Care, Vol.6, NO.4, pp201-204 63.Turano A., 1992 “New clinical data on the prophylaxis of infections in abdominal, gynecologic, and urologic surgery”, Am J Surg, Vol.164, pp16S-20S. 64.U.S. Congress, 1988, “Chapter 3: Evaluating Quality from the Perspective of Individual Consumer”, U.S. Congress, Office of Technology Assessment, pp51-66. 65.U.S. Congress, 1988, “Chapter 4: Hospital Mortality Rates”, U.S. Congress, Office of Technology Assessment, pp71-98. 66.Vuori H.V., 1988, EL control de calinded en los servicios sanitarios (Quality Control in Health Services), Barcelona: Masson. SA, 1 st ed. 67.Wagner C. et al., 1999, “A measuring instrument for evaluation of quality systems”, International Journal for Quality in Health Care, Vol.11, NO.2, pp119-130. 68.Wenzel R.P., 1992 “Preoperative antibiotic prophylaxis”, N Engl J Med, Vol.326, pp337-339. 69.Worning A.M., Mainz J., Klazinga N., Gotrik JK., Johnasen KS., 1992, “Policy on quality development for the medical profession”, Ugeskr Laeger, Vol.154, pp3523-3533. 70.Woods R.K., Dellinger E.P., 1998, “Current guidelines for antibiotic prophylaxis of surgicall wounds”, Am Fam Phy, Vol.57, NO.11, pp2731-2740. 71.Woods R.K., Dellinger E.P., 2004, “Current guidelines for antibiotic prophylaxis of surgicall wounds.” Available at: http://www.findarticles.com/cf_dls/m3225/n11_v57/20881338/p2/article.jhtml?term=. Accessed February 16. 72.Woodward C.A., Ostbye T.,Craighead J., Gold G., Wenghofer E.F., 2000, “Patient satisfaction as an indicator of quality care in dependent health facilities: Developing and assessing a tool to enhance public accountability”, Am J Med Qual, Vol.15, NO.3, pp94-105. 73.Wttewaall-Evelaar, E.W., 1990 “Meta-analysis of randomized controlled trials of antibiotic prophylaxis in abdominal hysterectomy”, Pharm Weekbl Sci, Vol.12, pp296-298; discussion 299. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/35748 | - |
dc.description.abstract | 本研究以開腹式子宮切除術為例,探討民國89年至91年間參加台灣醫療品質指標計畫(TQIP),手術預防性抗生素使用品質指標監測成效。研究概分為三大部分:(1)以描述性方式評估開腹式子宮切除術預防性抗生素使用各細項指標之監測結果;(2)探討開腹式子宮切除術預防性抗生素使用指標趨勢變化與醫療資源耗用之關係;(3)以焦點團體方式討論影響開腹式子宮切除術預防性抗生素使用之介入因素。
研究發現,研究期間開腹式子宮切除術使用預防性抗生素國內醫界已有高度共識,達95%,手術感染率亦維持穩定於0.5﹪左右。開腹式子宮切除術預防性抗生素之使用時機,劃刀前2小時使用預防性抗生素比率由44%提高至82%;劃刀前30分鐘使用預防性抗生素比率由民國90年40﹪進步到91年之54﹪,至91年底並已超越國際。至於預防性抗生素使用期間小於等於24小時比率於實施TQIP後已有顯著提升,由17﹪提高至41﹪,但仍有將近60﹪的個案未能符合預防性抗生素使用原則,與國際比較仍有改善空間。各項指標監測敏感度醫學中心高於非醫學中心,公立醫院高於私立醫院。開腹式子宮切除術論病例計酬個案平均藥費於實施TQIP前後大幅下降,其中90%為抗生素費用,平均每個案抗生素費用減少796元,降幅平均達44%,且預防性抗生素使用小於等於24小時達成率愈高,平均每個案抗生素費用愈低。非實驗組醫院該手術抗生素費用亦有下降趨勢。 適當的預防性抗生素使用可提升醫療品質,亦同時達醫療費用控制之目的。其指標監測成效,涉及醫院對預防性抗生素使用流程之組織行為改變,與臨床醫師對預防性抗生素處方行為之改變,須應用權變理論,營造有實證基礎之醫院內、外標竿學習環境,亦須內外部政策的介入。TQIP提供有實證基礎之自發性預防性抗生素使用監測機制,並提供國內、外預防性抗生素使用標竿學習機會,經由霍桑效應、學習效應與激勵效應,促進醫療品質之改善。 本研究建議醫院應持續監測預防性抗生素使用時機和使用期間,並同時監測手術傷口感染率,及營造促成改變之標竿學習環境;建議有關單位和主管機關擴大評估各項手術預防性抗生素使用成效,並訂定相關指引及管理規範。 | zh_TW |
dc.description.abstract | The purpose of this study is to evaluate the effects of monitoring medical care quality through the indicators of antibiotic prophylaxis, using abdominal hysterectomy as an example for the hospitals that were participating in the Taiwan Quality Indicator Project (TQIP) from 2000 to 2002. This study is composed of three parts, (1) to evaluate the outcomes of all sub indicators of antibiotic prophylaxis for abdominal hysterectomy by descriptive analysis, (2) to examine the relationship between the trends of those indicators and the utilization of medical resources, (3) to understand the influential factors for the use of antibiotic prophylaxis for abdominal hysterectomy by the focus-groups method.
The major finds are as the following: (1) the use of antibiotic prophylaxis for abdominal hysterectomy has been highly agreed (i.e., as high as 95%) among the practitioners in Taiwan, the surgical wound infection rate of this operation has been kept steady at 0.5% along the study years, (2) the rate of recriving antibiotic prophylaxis within two hours of incision has been risen from 44% to 82%, the rate of receiving antibiotic prophylaxis within 30 minutes of incision has been risen from 40% to 54% in one year (i.e., from 2000 to 2001) and this rate has exceeded the international level from year 2002, (3) as for the rate of receiving antibiotic prophylaxis for a duration of 24 hours or less has been risen significantly from 17% to 41%, however, there are still 60% participant hospitals do not meet the standard which indicates there is still room for improvement, (4) for all the indicators analyzed, the performance among medical centers are better than other hospitals and public hospitals are better than private hospitals, (5) the drug cost for the case payment of antibiotic prophylaxis for abdominal hysterectomy has been reduced largely, the reduction is mainly from the reduction of antibiotics, on average, the reduction is NT$796 per case which is 44% of the drug cost, and the reduction is larger when the rate of receiving antibiotic prophylaxis for abdominal hysterectomy within 24 hours or less is higher. The non experimental hospitals have a slight reduction in the drug cost during the study period. Based on the findings of this study, appropriate use of antibiotic prophylaxis can improve the quality of medical care and control medical cost at the same time. The performance of monitoring quality depends on organization behavioral change for the process of administering antibiotics prophylaxis in the hospital, as well as changes of prescribing behavior of the physicians. It is useful to use contingency theory to form evidence based bench marking and the intervention of relevant policies from within and outside the hospital. TQIP has provided this mechanism through voluntary participation and provision of reference information from Taiwan and international bench marking. The hospitals are motivated and learned from each other through Hawthorne effect and incentive effects which lead to improvements in the quality of medical care. The author suggests hospitals should continue to monitor the timing and duration of administering antibiotic prophylaxis, also, hospitals should monitor the surgical wound infection rate and create environment for improvement and bench marking. Policy makers and authorities should expend the scope of evaluation for the performance of antibiotic prophylaxis, and should establish related guidelines and principals for management of medical care quality. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T07:08:05Z (GMT). No. of bitstreams: 1 ntu-94-P91743008-1.pdf: 1084338 bytes, checksum: 7715604842eb73db441b684803136f34 (MD5) Previous issue date: 2005 | en |
dc.description.tableofcontents | 謝詞 ---------------------------------------------------- 四
中文摘要 ---------------------------------------------------- 五 英文摘要 ---------------------------------------------------- 七 表 次 ------------------------------------------------------ 一一 圖 次 ------------------------------------------------------ 一三 第一章 緒論 ------------------------------------------------- 1 第一節 研究動機 ------------------------------------------- 1 第二節 研究目的 ------------------------------------------- 2 第三節 台灣醫療品質指標計畫之推行概況 --------------------- 3 第二章 文獻探討 --------------------------------------------- 8 第一節 醫療品質定義 --------------------------------------- 8 第二節 醫療品質成效量測 ----------------------------------- 11 第三節 外科預防性抗生素使用在開腹式子宮切除術上之實證 ----- 15 第四節 品質促進與品質成本 --------------------------------- 19 第五節 品質管理與組織行為 --------------------------------- 23 第三章 研究方法 -------------------------------------------- 26 第一節 研究範圍 ------------------------------------------- 26 第二節 研究設計與架構 ------------------------------------- 28 第三節 研究假說 ------------------------------------------- 32 第四節 操作性定義 ----------------------------------------- 33 第五節 資料處理與統計方法 --------------------------------- 34 第四章 研究結果 --------------------------------------------- 37 第一節 開腹式子宮切除術預防性抗生素使用指標監測結果 ------- 37 第二節 開腹式子宮切除術資源耗用情形 ----------------------- 43 第三節 影響預防性抗生素指標監測成效之因素 ---------------- 47 第五章 討論 ------------------------------------------------- 53 第一節 開腹式子宮切除術預防性抗生素指標之持續監測 --------- 53 第二節 開腹式子宮切除術預防性抗生素使用情形 --------------- 55 第三節 開腹式子宮切除術醫療資源耗用情形 ------------------- 63 第四節 影響醫院開腹式子宮切除術預防性抗生素使用因素 ------- 70 第五節 手術預防性抗生素監測與組織行為理論 ----------------- 75 第六節 研究限制 ------------------------------------------- 80 第六章 結論與建議 ------------------------------------------ 81 第一節 結論 ----------------------------------------------- 81 第二節 建議 ---------------------------------------------- 83 參考文獻 ---------------------------------------------------- 85 附錄A ------------------------------------------------------- 94 附錄B ------------------------------------------------------- 95 附錄C ------------------------------------------------------- 99 | |
dc.language.iso | zh-TW | |
dc.title | 手術預防性抗生素品質指標監測成效評估-以開腹式子宮切除術為例 | zh_TW |
dc.title | Assessment on monitoring antibiotic prophylaxis for abdominal hysterectomy | en |
dc.type | Thesis | |
dc.date.schoolyear | 93-2 | |
dc.description.degree | 碩士 | |
dc.contributor.coadvisor | 劉順仁 | |
dc.contributor.oralexamcommittee | 謝博生 | |
dc.subject.keyword | 開腹式子宮切除術,預防性抗生素,品質指標,成效評估,醫療資源耗用,組織行為, | zh_TW |
dc.subject.keyword | antibiotic prophylaxis for abdominal hysterectomy,antibiotic prophylaxis,quality indicator,assessment of performance,utilization of medical resources,organization behavior, | en |
dc.relation.page | 102 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2005-07-27 | |
dc.contributor.author-college | 管理學院 | zh_TW |
dc.contributor.author-dept | 高階公共管理組 | zh_TW |
顯示於系所單位: | 高階公共管理組 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-94-1.pdf 目前未授權公開取用 | 1.06 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。